| Name | Title | Contact Details |
|---|
Bovie Medical is setting the standard for surgi-center and hospital-based electrosurgical generators and accessories with a range of “state of the art” models: the Aaron 900™, the Aaron 940™, the Aaron 950™, the Aaron 1250™, the Aaron 2250™, and the Aaron 3250™ along with the IDS-200™, IDS-300™, and ICON Gi™. This full line is the most complete offering of any USA manufactured electrosurgical generator product. The feature-packed generators are designed from the ground up to be extremely reliable, and are UL and Canadian Standards compliant. All of these generators are available for private labeling. Over the past decade, we have expanded our manufacturing capabilities to include a full line of disposable electrosurgical electrodes in blade, ball, needle, loop and laparoscopic form. The reusable ES pencils, with a full compliment of reusable electrodes and bipolar forceps, enhance our ever-expanding line of products. In addition to electrosurgery, Bovie Medical is the number-one producer of battery-operated cauteries in the world. Its product lines, distribution channels, and renowned industry reputation continue to grow. Bovie Medical continues to improve and expand its product offerings and services, as well as continuing its excellent record of support to existing customers.
Precision Biopsy, LLC was formed in partnership with Allied Minds to develop and commercialize novel technology for the accurate diagnosis of prostate cancer. The company’s diagnostic technology uses advanced spectroscopy imaging techniques in combination with tissue biopsy. For the first time, this unique ability will eliminate random prostate biopsies that are subject to sampling errors and can lead to inaccurate grading and staging of the disease. The scientific founders, professors Priya Werahara and John Daily of the University of Colorado, have long studied the morphology of cancer tissue. Combining their knowledge of advanced spectroscopy techniques has resulted in the ability to image the precise location of cancer in the prostate.
BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.
ContourMD is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
medikmark, Inc. is a Waukegan, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.